The present invention features solid compositions comprising amorphous Compound I. A solid dispersion of the present invention also contains a pharmaceutically acceptable hydrophilic polymer and a pharmaceutically acceptable surfactant. Compound I may be formulated in an amorphous solid dispersion which comprises a pharmaceutically acceptable hydrophilic polymer and preferably a pharmaceutically acceptable surfactant.本發明係關於固態組合物,其包含非晶形化合物I。本發明之固態分散體亦含有醫藥學上可接受之親水性聚合物及醫藥學上可接受之界面活性劑。化合物I可調配於包含醫藥學上可接受之親水性聚合物及較佳醫藥學上可接受之界面活性劑的非晶形固態分散體中。